Cargando…
Intensity of and Adherence to Lipid‐Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease
BACKGROUND: The effectiveness of lipid‐lowering therapy (LLT) is affected by both intensity and adherence. This study evaluated the associations of LLT intensity, adherence, and the combination of these 2 aspects of LLT management with the risk of major adverse cardiovascular events (MACE) in people...
Autores principales: | Mazhar, Faizan, Hjemdahl, Paul, Clase, Catherine M., Johnell, Kristina, Jernberg, Tomas, Sjölander, Arvid, Carrero, Juan Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707817/ https://www.ncbi.nlm.nih.gov/pubmed/35861825 http://dx.doi.org/10.1161/JAHA.122.025813 |
Ejemplares similares
-
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
por: Tang, Bowen, et al.
Publicado: (2023) -
Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease
por: Trevisan, Marco, et al.
Publicado: (2021) -
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction
por: Trevisan, Marco, et al.
Publicado: (2020) -
Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations
por: KRANTZ, Åsa, et al.
Publicado: (2023) -
Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
por: Alkas, Jim, et al.
Publicado: (2022)